Autism: Clinical Trials

10 trials for Autism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 unknown, 1 recruiting. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 6, Unknown 3, Recruiting 1

Follow Autism: new trials by email Literature Review of Autism trials Research Report on Autism

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine
Adderall XR (mixed salts amphetamine), Placebo - Attention Deficit Hyperactivity Disorder (ADHD), Autism
Phase 4RecruitingGagan Joshi1962026-02-012026-03-06
Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)
Open-label Treatment with Omega-3 Fatty Acids + Inositol, Open-label Treatment with N-acetylcysteine - Non-verbal Learning Disorder, Autism Spectrum Disorder
Phase 4CompletedMassachusetts General Hospital542019-05-202025-06-05
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
Very Low Dose Quillivant XR, Low Dose Quillivant XR, Moderate Dose Quillivant XR - ADHD, Autism
Phase 4CompletedSeattle Children's Hospital362014-09-012017-08-01
Study to Evaluate the Efficacy and Safety of Aripiprazole
Aripiprazole - Autism
Phase 4UnknownYoo-Sook Joung792014-02-012014-03-11
An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum
Gammaplex 5% - Autism, Autistic Disorder
Phase 4UnknownIsaac Melamed302013-06-012015-04-16
Treatment With Acetyl-Choline Esterase Inhibitors in Children With Autism Spectrum Disorders
Acetyl-Choline Esterase Inhibitors and Choline supplements, Indistinguishable placebo tablets, matching both donepezil and choline - Autism
Phase 4UnknownSheba Medical Center842010-03-012016-10-14
Atomoxetine, Placebo and Parent Management Training in Autism
atomoxetine, Placebo, Parent Management Training - Autism, Pervasive Development Disorder
Phase 4CompletedUniversity of Rochester1282008-10-012016-02-04
A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder
Placebo, Risperidone high dose, Risperidone low dose - Autistic Disorder, Autism
Phase 4CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.962007-12-012014-05-09
Minocycline to Treat Childhood Regressive Autism
Minocycline - Autism, Minocycline
Phase 4CompletedNational Institute of Mental Health (NIMH)112006-11-012015-12-11
Divalproex Sodium ER in Adult Autism
Divalproex Sodium ER - Autism
Phase 4CompletedMontefiore Medical Center102005-04-012018-05-31

Narrower conditions

Autistic Disorder (10)  ·  Attention Deficit Disorder with Hyperactivity (3)  ·  Asperger Syndrome (2)  ·  Autism Spectrum Disorder (2)  ·  Child Development Disorders, Pervasive (2)  ·  Aggression (1)  ·  Learning Disabilities (1)  ·  cyclopia sequence (1)

Broader conditions

Mental Disorders (10)  ·  Neurodevelopmental Disorders (10)  ·  Autism Spectrum Disorder (8)  ·  Child Development Disorders, Pervasive (8)  ·  Attention Deficit and Disruptive Behavior Disorders (3)  ·  Aberrant Motor Behavior in Dementia (1)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Communication Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Social Behavior (1)

Interventions

Acetylcysteine (1)  ·  Aripiprazole (1)  ·  Atomoxetine Hydrochloride (1)  ·  Choline (1)  ·  Fatty Acids, Omega-3 (1)  ·  Inositol (1)  ·  Methylphenidate (1)  ·  Minocycline (1)  ·  Risperidone (1)  ·  SLI381 (1)

Sponsors

Gagan Joshi (1)  ·  Isaac Melamed (1)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)  ·  Massachusetts General Hospital (1)  ·  Montefiore Medical Center (1)  ·  National Institute of Mental Health (NIMH) (1)  ·  Seattle Children's Hospital (1)  ·  Sheba Medical Center (1)  ·  University of Rochester (1)  ·  Yoo-Sook Joung (1)

Countries

United States (8)  ·  Israel (1)  ·  Philippines (1)  ·  South Korea (1)  ·  Thailand (1)

Top investigators

Benjamin Handen, PhD (1)  ·  Dorit Ben-Shalom, Ph.D (1)  ·  Eric Hollander, MD (1)  ·  Gagan Joshi, MD (1)  ·  Isaac Melamed, MD (1)  ·  Janet Wozniak, MD (1)  ·  Lidia Gabis, MD (1)  ·  Mark Stein, PhD (1)  ·  Michael Aman, PhD (1)  ·  Rotem Chayu Ben-Hur, MA (1)  ·  Shefer Shahar, Dr. (1)  ·  Tristram Smith, PhD (1)  ·  Yoo-Sook Joung, MD. PhD. (1)

Results publications

PMID 37811711, PMID 20377705, PMID 23212807, PMID 23566357, PMID 24350813, PMID 26231264, PMID 26506581, PMID 27663942, PMID 29022125, PMID 29694241, PMID 36112116, PMID 37267443